Description
UNDERSTANDING TIRZEPATIDE
Tirzepatide is a synthetic peptide that mimics the effects of two natural hormones: GLP-1 (Glucagon-Like Peptide-1) and GIP (Gastric Inhibitory Polypeptide). By activating both receptors, Tirzepatide provides a synergistic effect on glucose control and appetite regulation. It is administered via a weekly subcutaneous injection.
Tirzepatide exerts its effects through several mechanisms:
1. Enhanced Insulin Secretion: Stimulates insulin release in response to meals, aiding in blood sugar control.
2. Suppression of Glucagon: Reduces glucagon levels, preventing excess glucose production by the liver.
3. Appetite Regulation: Acts on the brain to promote satiety, leading to reduced food intake.
4. Slowed Gastric Emptying: Delays stomach emptying, contributing to prolonged feelings of fullness.
5. Fat Loss Promotion: Encourages the breakdown of fat stores, supporting weight loss efforts.
BENEFITS:
1. Weight Loss
Tirzepatide leads to significant weight reduction. Users experienced an average weight loss of up to 15.7%. This effect is dose-dependent, with higher doses yielding more substantial results.
2. Blood Sugar Control
Tirzepatide has shown efficacy in improving glycemic control in individuals with type 2 diabetes. It has been associated with significant reductions in HbA1c levels, aiding in long-term blood sugar management.
3. Diabetes Prevention
In a study involving adults with pre-diabetes and obesity, nearly 99% of participants remained diabetes-free after three years of treatment with Tirzepatide. The risk of progressing to type 2 diabetes was reduced by 94%, highlighting its potential in diabetes prevention.
4. Cardiometabolic Health
Tirzepatide has been shown to improve various cardiometabolic risk factors, including reductions in blood pressure, cholesterol levels, and fasting insulin. These benefits contribute to overall cardiovascular health.
ADMINISTRATION:
Use for subcutaneous injection only
DOSAGE RECOMMENDATION:
Week 1-4 | 2.5mg once a week
Week 5-8 | 5mg once a week
Week 9-12 | 7.5mg once a week
Week 13-16 | 10mg once a week
From week 17 | 12.5-15mg once a week
(15 clicks – 1mg)





